United States Antimony Corporation (UAMY) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the UAMY SEC filings page.
United States Antimony Corporation (UAMY) reported $36.4M in revenue over the twelve months to Jun 30, 2026, up 41.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The business expanded sharply in FY2025, but its larger scale remains funded by financing while operations and investment consumed cash.
Revenue more than doubled from FY2024 to FY2025, yet the operating margin remained negative at-21.6% , showing that added volume did not cover operating costs. The swing from positive free cash flow in FY2024 to-$37.5M in FY2025, alongside operating cash flow of-$9.7M , indicates expansion consumed cash beyond the reported operating shortfall.
Balance-sheet expansion was financing-led: assets reached
Gross economics improved, with gross margin reaching
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of United States Antimony Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
United States Antimony Corporation held $30.5M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $9.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and United States Antimony Corporation scores 62/100 among other emerging companies.
United States Antimony Corporation had 143M shares outstanding at the end of fiscal year 2025, against 115M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and United States Antimony Corporation scores 41/100 among other emerging companies.
Not available for United States Antimony Corporation, and counted as zero in the overall score.
United States Antimony Corporation reported revenue of $39.3M in fiscal year 2025, against $14.9M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and United States Antimony Corporation scores 87/100 among other emerging companies.
United States Antimony Corporation's operations used $9.7M of cash in fiscal year 2025, against $2.2M generated in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and United States Antimony Corporation scores 19/100 among other emerging companies.
United States Antimony Corporation's cash, cash equivalents and investments came to $30.5M at the end of fiscal year 2025, against $13.0M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and United States Antimony Corporation scores 77/100 among other emerging companies.
United States Antimony Corporation scores 25.76, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($556.8M) relative to total liabilities ($13.0M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
United States Antimony Corporation passes 4 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
United States Antimony Corporation reported a net loss of $4.3M while operations used $9.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
United States Antimony Corporation generated $7.9M in revenue in Q2 2026. This represents a decrease of 24.7% from the same quarter a year earlier. Against the prior quarter it is up 16.8%.
United States Antimony Corporation's EBITDA was -$6.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 2272.8% from the same quarter a year earlier. Against the prior quarter it is up 9.0%.
United States Antimony Corporation reported $110K in net income in Q2 2026. This represents a decrease of 39.3% from the same quarter a year earlier. Against the prior quarter it is up 101.0%.
Not reported for Q2 2026.
Cash & Balance Sheet
United States Antimony Corporation recorded an outflow of $18.9M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 163.9% from the same quarter a year earlier. Against the prior quarter it is up 23.3%.
United States Antimony Corporation held $42.3M in cash against $159K in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
United States Antimony Corporation's gross margin was 7.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 19.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.0 percentage points.
United States Antimony Corporation's operating margin was -88.1% in Q2 2026, reflecting core business profitability. This is down 88.3 percentage points from the same quarter a year earlier.
United States Antimony Corporation's net profit margin was 1.4% in Q2 2026, showing the share of revenue converted to profit. This is down 0.3 percentage points from the same quarter a year earlier.
United States Antimony Corporation's ROE was 0.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 8.6 percentage points.
Capital Allocation
United States Antimony Corporation spent $2.8M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 43.8%.
United States Antimony Corporation invested $10.2M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 56.7% from the same quarter a year earlier. Against the prior quarter it is down 18.7%.
Not reported for Q2 2026.
UAMY Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.9M-24.7% | $6.8M-3.1% | $13.0M+131.4% | $8.7M+238.3% | $10.5M+187.3% | $7.0M+127.9% | $5.6M+161.5% | $2.6M+24.6% |
| Cost of Revenue | $7.3M-4.5% | $5.7M+22.6% | $10.4M+134.4% | $6.7M+211.3% | $7.7M+218.6% | $4.6M+86.4% | $4.4M-32.3% | $2.1M+19.0% |
| Gross Profit | $583K-79.4% | $1.1M-53.2% | $2.7M+120.3% | $2.0M+375.1% | $2.8M+127.0% | $2.4M+302.3% | $1.2M+127.4% | $424K+64.0% |
| SG&A Expenses | $1.6M+91.0% | $1.3M+141.9% | $849K+93.4% | $883K+44.5% | $843K+67.6% | $551K+10.1% | $439K-54.5% | $611K+110.6% |
| Operating Income | -$7.0M-34992.3% | -$7.5M-2199.8% | -$3.9M-261.1% | -$4.9M-451.9% | $20K-64.3% | $358K+176.1% | -$1.1M+83.5% | -$891K-145.0% |
| EBITDA | -$6.5M-2272.8% | -$7.1M-1210.5% | -$3.6M-957.2% | -$4.6M-501.1% | $298K+74.5% | $640K+275.7% | -$340K+94.2% | -$771K-185.4% |
| Income Tax | $0 | N/A | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $110K-39.3% | -$11.3M-2166.6% | -$287K+67.5% | -$4.8M-557.1% | $182K-10.5% | $547K+269.3% | -$883K+75.2% | -$728K+55.8% |
| EPS (Basic) | N/A | -$0.08 | -$0.010.0% | -$0.04-300.0% | N/A | $0.00 | -$0.01+100.0% | -$0.01-100.0% |
| EPS (Diluted) | N/A | -$0.08 | -$0.01 | -$0.04 | N/A | $0.00 | -$0.01 | -$0.01-100.0% |
| Diluted Shares (Avg) | 152M+19.3% | 142M+15.7% | N/A | 123M | 127M+16.8% | 122M+13.4% | N/A | 108M+2.0% |
Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.
UAMY Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $190.6M+301.3% | $148.0M+274.8% | $153.9M+344.3% | $79.9M+168.5% | $47.5M+64.2% | $39.5M+41.0% | $34.6M+23.3% | $29.8M-3.8% |
| Current Assets | $76.6M+333.5% | $48.4M+94.9% | $54.7M+164.7% | $31.8M+112.0% | $17.7M+21.0% | $24.8M+77.3% | $20.7M+46.9% | $15.0M-9.8% |
| Cash & Equivalents | $42.3M+627.5% | $3.4M-82.0% | $30.5M+67.8% | $18.5M+42.4% | $5.8M-53.1% | $18.8M+57.8% | $18.2M+52.7% | $13.0M+0.8% |
| Short-Term Investments | $0-100.0% | $0 | $0 | $1.3M | $8.8M | $0-100.0% | $0-100.0% | $0 |
| Inventory | $21.6M+217.1% | $22.0M+451.9% | $12.5M+905.2% | $8.4M+770.2% | $6.8M+1373.4% | $4.0M+511.2% | $1.2M-10.1% | $967K-48.5% |
| Accounts Receivable | $2.6M+2.5% | $2.5M+27.3% | $4.2M+283.1% | $1.9M+139.8% | $2.5M+82.5% | $2.0M+86.6% | $1.1M+75.9% | $792K-43.1% |
| Long-Term Investments | $0 | $0 | $0 | $18.9M | $0 | $0 | $0 | $0 |
| Total Liabilities | $9.6M-4.0% | $16.2M+133.9% | $13.0M+114.7% | $8.1M+75.8% | $10.0M+209.6% | $6.9M+165.5% | $6.0M+134.7% | $4.6M+150.7% |
| Current Liabilities | $6.6M-17.0% | $13.4M+183.3% | $10.2M+154.0% | $6.3M+160.4% | $8.0M+538.7% | $4.7M+420.7% | $4.0M+346.4% | $2.4M+87.9% |
| Non-Current Liabilities | $3.0M+48.0% | $2.8M+27.4% | $2.8M+37.2% | $1.9M-15.8% | $2.0M+1.0% | $2.2M+29.1% | $2.0M+21.4% | $2.2M+292.6% |
| Long-Term Debt | $159K+24.5% | $23K-85.5% | $58K-70.1% | $93K-59.3% | $128K-51.3% | $162K | $195K | $229K+27.3% |
| Total Equity | $181.0M+382.6% | $131.9M+304.7% | $141.0M+392.8% | $71.8M+185.6% | $37.5M+45.9% | $32.6M+28.3% | $28.6M+12.1% | $25.1M-13.6% |
| Retained Earnings | -$56.7M-40.2% | -$56.8M-39.9% | -$45.5M-10.5% | -$45.2M-12.3% | -$40.4M-2.2% | -$40.6M-2.2% | -$41.1M-4.4% | -$40.3M-12.3% |
Not reported in any period shown, so not listed: Goodwill.
UAMY Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$8.7M-1279.7% | -$12.1M-597.4% | -$3.5M-394.6% | -$3.9M-1039.6% | -$628K-210.9% | -$1.7M-2759.3% | $1.2M+129.1% | $411K-13.0% |
| Depreciation & Amortization | $515K+85.7% | $410K+45.6% | $327K-56.1% | $280K+134.0% | $278K+142.4% | $282K+165.6% | $746K+4.8% | $120K+28.0% |
| Stock-Based Compensation | $2.9M+395.0% | $4.8M+1870.0% | N/A | $3.9M+2425.2% | $587K+518.3% | $245K+19.2% | N/A | $153K |
| Capital Expenditures | $10.2M+56.7% | $12.6M+1358.7% | $11.7M+5556.4% | $8.7M+11892.7% | $6.5M+6564.3% | $863K+1536.2% | $208K+8.5% | $72K-49.0% |
| Free Cash Flow | -$18.9M-163.9% | -$24.6M-850.7% | -$15.2M-1667.0% | -$12.5M-3800.3% | -$7.2M-1630.0% | -$2.6M-21147.6% | $971K+122.9% | $339K+2.4% |
| Investing Cash Flow | $1.5M+108.8% | -$12.6M-1359.3% | -$51.4M-27872.1% | -$18.6M-7798.4% | -$16.5M-16758.6% | -$862K-42342.7% | -$184K-203.2% | $242K+240.7% |
| Financing Cash Flow | $46.1M+1020.1% | -$2.6M-183.2% | $67.1M+1493.3% | $35.1M+109667.2% | $4.1M+23210.6% | $3.2M+14983.3% | $4.2M+2071.4% | -$32K-102.4% |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0 |
| Share Buybacks | $2.8M | $5.0M | $40K | N/A | N/A | N/A | N/A | N/A |
UAMY Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.4%-19.6pp | 16.4%-17.5pp | 20.3%-1.0pp | 23.1%+6.7pp | 27.0%-7.2pp | 33.9%+14.7pp | 21.4% | 16.5%+4.0pp |
| Operating Margin | -88.1%-88.3pp | -110.8% | -30.1%-10.8pp | -56.5%-21.9pp | 0.2%-1.3pp | 5.1%+20.4pp | -19.3% | -34.6%-17.0pp |
| Net Margin | 1.4%-0.3pp | -166.5% | -2.2%+13.5pp | -54.9%-26.7pp | 1.7%-3.8pp | 7.8%+18.3pp | -15.7% | -28.3%+51.4pp |
| Return on Equity | 0.1%-0.4pp | -8.6%-10.2pp | -0.2%+2.9pp | -6.7%-3.8pp | 0.5%-0.3pp | 1.7%+2.9pp | -3.1%+10.9pp | -2.9%+2.8pp |
| Return on Assets | 0.1%-0.3pp | -7.6%-9.0pp | -0.2%+2.4pp | -6.0%-3.5pp | 0.4%-0.3pp | 1.4%+2.5pp | -2.5%+10.1pp | -2.5%+2.9pp |
| Current Ratio | 11.54+9.3x | 3.62-1.6x | 5.38+0.2x | 5.08-1.2x | 2.21-9.5x | 5.26-10.2x | 5.16-10.5x | 6.24-6.8x |
| Debt-to-Equity | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.010.0x | 0.010.0x | 0.010.0x |
| Asset Turnover | 0.04-0.2x | 0.05-0.1x | 0.08-0.1x | 0.110.0x | 0.22+0.1x | 0.18+0.1x | 0.16+0.1x | 0.090.0x |
| FCF Margin | -238.4% | -363.2% | -116.7% | -144.1% | -68.0%-80.8pp | -37.0%-37.4pp | 17.2% | 13.2%-2.9pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| United States Antimony Corporation UAMY | FY2025 | $39.3M | -$4.3M | -11.1% | $556.8M | 48/100 |
| Critical Metals Corp. CRML | FY2025 | N/A | -$51.9M | N/A | $1.0B | — |
| Sigma Lithium Corporation SGML | FY2025 | $110.0M | -$50.2M | -45.6% | $1.1B | 14/100 |
| Standard Lithium Ltd. SLI | FY2025 | N/A | -$48.4M | N/A | $407.2M | — |
| Lithium Argentina AG LAR | FY2025 | N/A | -$76.9M | N/A | $881.2M | — |
| Nexa Resources S.A. NEXA | FY2025 | $3.0B | $223.1M | 7.4% | $1.7B | 31/100 |
Where United States Antimony Corporation Ranks
Frequently Asked Questions
What is United States Antimony Corporation's annual revenue?
United States Antimony Corporation (UAMY) reported $39.3M in total revenue for fiscal year 2025. This represents a 162.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is United States Antimony Corporation's revenue growing?
United States Antimony Corporation (UAMY) revenue grew by 162.8% year-over-year, from $14.9M to $39.3M in fiscal year 2025.
Is United States Antimony Corporation profitable?
No, United States Antimony Corporation (UAMY) reported a net income of -$4.3M in fiscal year 2025, with a net profit margin of -11.1%.
What is United States Antimony Corporation's EBITDA?
United States Antimony Corporation (UAMY) had EBITDA of -$7.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does United States Antimony Corporation have?
As of fiscal year 2025, United States Antimony Corporation (UAMY) had $30.5M in cash and equivalents against $58K in long-term debt.
What is United States Antimony Corporation's gross margin?
United States Antimony Corporation (UAMY) had a gross margin of 25.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is United States Antimony Corporation's operating margin?
United States Antimony Corporation (UAMY) had an operating margin of -21.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is United States Antimony Corporation's net profit margin?
United States Antimony Corporation (UAMY) had a net profit margin of -11.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is United States Antimony Corporation's return on equity (ROE)?
United States Antimony Corporation (UAMY) has a return on equity of -3.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is United States Antimony Corporation's free cash flow?
United States Antimony Corporation (UAMY) recorded an outflow of $37.5M in free cash flow during fiscal year 2025. This represents a -2195.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is United States Antimony Corporation's operating cash flow?
United States Antimony Corporation (UAMY) recorded an outflow of $9.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are United States Antimony Corporation's total assets?
United States Antimony Corporation (UAMY) had $153.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are United States Antimony Corporation's capital expenditures?
United States Antimony Corporation (UAMY) invested $27.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is United States Antimony Corporation's current ratio?
United States Antimony Corporation (UAMY) had a current ratio of 5.38 as of fiscal year 2025, which is generally considered healthy.
What is United States Antimony Corporation's debt-to-equity ratio?
United States Antimony Corporation (UAMY) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is United States Antimony Corporation's return on assets (ROA)?
United States Antimony Corporation (UAMY) had a return on assets of -2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is United States Antimony Corporation's P/E ratio?
United States Antimony Corporation (UAMY) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $556.8M as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is United States Antimony Corporation's price-to-sales ratio?
United States Antimony Corporation (UAMY) trades at 15.3x sales, its market capitalization divided by revenue of $36.4M revenue, trailing 12 months to June 30, 2026. The market capitalization is $556.8M as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does United States Antimony Corporation's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, United States Antimony Corporation (UAMY) held $30.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $9.7M over that year. Dividing the one by the other, the reported balance equals about 38 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is United States Antimony Corporation's Altman Z-Score?
United States Antimony Corporation (UAMY) has an Altman Z-Score of 25.76, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is United States Antimony Corporation's Piotroski F-Score?
United States Antimony Corporation (UAMY) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are United States Antimony Corporation's earnings high quality?
United States Antimony Corporation (UAMY) reported a net loss of $4.3M while operations used $9.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is United States Antimony Corporation?
United States Antimony Corporation (UAMY) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.